USA005 — Omaha, Nebraska

USA005 is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

USA005 has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer, Glioblastoma Multiforme.

Sponsors: Gan and Lee Pharmaceuticals, USA.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USA005?

USA005 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USA005 conducted?

USA005 has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer, Glioblastoma Multiforme.

Is USA005 accredited by Crixeo Health?

USA005 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USA005?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.